Source comparison
Climbers Researching BPC-157: Preparation Comparison
Compounding Pharmacy (503B) FDA-registered facility synthesis State pharmacy board oversight, not FDA drug approval 98–99.5% via HPLC Yes. Bacteriostatic water provided $180–$280 Highest traceability and batch testing. Requires prescription Research Peptide Su
This comparison does not assign a generated winner or score.
- Compounding Pharmacy (503B)
- FDA-registered facility synthesis
- State pharmacy board oversight, not FDA drug approval
- 98–99.5% via HPLC
- Yes. Bacteriostatic water provided
- $180–$280
- Highest traceability and batch testing. Requires prescription
- Research Peptide Supplier
- Contract lab synthesis (China/India common)
- No drug oversight. Research use only label
- 95–99% claimed, third-party COA varies
- Yes. Buyer sources bacteriostatic water
- $60–$120
- Quality inconsistent. COAs may not match actual batch shipped
- Oral Capsule (Supplement Market)
- Unknown peptide source, often proprietary blend
- Dietary supplement framework. No pre-market approval
- Not disclosed, likely <90% if BPC-157 present at all
- No. Capsule form
- $45–$90
- Bioavailability unproven for oral BPC-157. Gastric acid degrades peptide structure
- Pre-Mixed Injectable (Grey Market)
- Unknown synthesis origin
- No regulatory framework
- Unknown. No batch testing
- No. Arrives in solution
- $100–$200
- Contamination and potency risk highest. Avoid entirely